Supplementary figure 2. Concentration-effect curve for dupilumab level and ΔEASI at 12 weeks in patients on dupilumab monotherapy only.

Concentration-effect curve showing the dupilumab serum level in μg/mL at 12 weeks on the x-axis and correlating ΔEASI at 12 weeks (versus baseline) on the y-axis. All patients were sorted from low to high drug concentration, with each dot representing the mean concentration with SDs and correlating ΔEASI for 10 patients (last group 8 patients). Patients that received systemic corticosteroids were excluded here.